Contrasting clinical outcomes and socio‐economic impact of young versus elderly‐onset oral squamous cell carcinoma, a novel health economic analysis

Manraj Singh,Krishnakumar Thankappan,Deepak Balasubramanian,Vijay Pillai,Vivek Shetty,Vidyabhushan Rangappa,Naveen Hedne Chandrasekhar,Vikram Kekatpure,Moni Abraham Kuriakose,Arvind Krishnamurthy,Arun Mitra,Arun Pattatheyil,Prateek Jain,Subramania Iyer,N. Gopalakrishna Iyer,Narayana Subramaniam,the Head and Neck Cooperative Oncology Group
DOI: https://doi.org/10.1002/cam4.6747
IF: 4.711
2024-01-17
Cancer Medicine
Abstract:Objectives The incidence of young‐onset oral squamous cell carcinoma (OSCC) is growing, even among non‐smokers/drinkers. The effects of adverse histopathological features on long‐term oncologic outcomes between the young and old are controversial and confounded by significant heterogeneity. Few studies have evaluated the socio‐economic impact of premature mortality from OSCC. Our study seeks to quantify these differences and their economic impact on society. Materials and Methods Four hundred and seventy‐eight young (<45 years) and 1660 old patients (≥45 years) with OSCC were studied. Logistic regression determined predictors of recurrence and death. Survival analysis was calculated via the Kaplan–Meier method. A separate health economic analysis was conducted for India and Singapore. Years of Potential Productive Life Lost (YPPLL) were estimated with the Human Capital Approach, and premature mortality cost was derived using population‐level data. Results Adverse histopathological features were seen more frequently in young OSCC: PNI (42.9% vs. 35%, p = 0.002), LVI (22.4% vs. 17.3%, p = 0.013) and ENE (36% vs. 24.5%, p
oncology
What problem does this paper attempt to address?